The short version
20 companies supply this market — deep enough that no single failure threatens the supply.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Rabeprazole Sodium
Rabeprazole Sodium · RABEPRAZOLE SODIUM 20 mg/1 · Tablet, Delayed Release · Oral · Asclemed USA, Inc.
NDC 76420-0107-90 · 90 TABLET, DELAYED RELEASE in 1 BOTTLE · ANDA · View full market →
Medicare Part D
All Part D pricing →Matched to CMS's representative package for this drug (NDC 62175-0302-32) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.
ⓘ How this was built
Data sources
- CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method
Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.
Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.
Plans pay at point of saleⓘ
$0.3109per unit
middle half $0.2481–$0.6812 · 4,012 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $0.3109
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
73%of plans cover it
tier 3 · prior auth 0% · step therapy 0% · qty limit 72%
*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.
NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
0.1%chance of a new FDA shortage posting for rabeprazole sodium (oral solid) in the next 90 days
sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Where it's made
- Asclemed Usa Inc. Dba EnovachemUnited Statesrelabel · repack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA205761
- TE code
- AB
- Approval date
- Feb 17, 2017
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Rabeprazole Sodium (Tablet, Delayed Release)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Advanced Rx of Tennessee, LLC | RABEPRAZOLE SODIUM 20 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Aurobindo Pharma Limited | RABEPRAZOLE SODIUM 20 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Bryant Ranch Prepack | RABEPRAZOLE SODIUM 20 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Proficient Rx LP | RABEPRAZOLE SODIUM 20 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Remedyrepack Inc. | RABEPRAZOLE SODIUM 20 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| St. Mary's Medical Park Pharmacy | RABEPRAZOLE SODIUM 20 mg/1 | Jul 15, 2026 | Sep 3, 2026 |
| Advagen Pharma Limited | RABEPRAZOLE SODIUM 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Advanced Rx Pharmacy of Tennessee, LLC | RABEPRAZOLE SODIUM 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Ascend Laboratories, LLC | RABEPRAZOLE SODIUM 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Chartwell RX, LLC | RABEPRAZOLE SODIUM 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Golden State Medical Supply, Inc. | RABEPRAZOLE SODIUM 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Lannett Company, Inc. | RABEPRAZOLE SODIUM 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Phoenix Rx Llc | RABEPRAZOLE SODIUM 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Preferred Pharmaceuticals Inc. | RABEPRAZOLE SODIUM 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Preferred Pharmaceuticals, Inc. | RABEPRAZOLE SODIUM 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Torrent Pharmaceuticals Limited | RABEPRAZOLE SODIUM 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Waylis Therapeutics LLC | RABEPRAZOLE SODIUM 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| A-S Medication Solutions | RABEPRAZOLE SODIUM 20 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
| Asclemed USA, Inc. | RABEPRAZOLE SODIUM 20 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
| Direct Rx | RABEPRAZOLE SODIUM 20 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Rabeprazole Sodium — NDC 76420-0107-90," retrieved September 3, 2026, https://drugdashboards.com/drug/76420010790.
Free to cite with attribution — see how the data is put together.